Of course, some results of peripheral blood immunophenotyping are characteristic of the analyzed disease subunits, such as a higher number of CD19+ B cells in CLL patients and a higher number of TCD3+ cells in CVID patients. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.